The worldwide cell culture market is expected to witness significant development. The trends relevant for the current market include the advantages of cell-culture-based vaccines. The increased public awareness of these benefits is better nowadays. More professionals are venturing into cell-based research. The researchers also receive significant or better financial support that fuels the growth.
The single-used technologies are growing in popularity. Sophisticated cell-culture technologies are more available than in previous years.
Additionally, novel and cutting-edge items fuels the market’s expansion.
In 2020, there were reportedly 19.3 million new instances of cancer worldwide, and according to GLOBOCAN Statistics, that number is expected to rise to 30.2 million by 2040. These statistics are going to be important for the global cell culture market.
However, not all of these factors will be relevant for emerging economies. The research aspect is comparatively less robust in the case of emerging nations due to a lack of sufficient funding.
It is really interesting to learn about cell culture innovators at this juncture. This edition focuses on the latest trends in the industry. Additionally, there is a list of top 10 cell culture innovators for you to choose from.
Resilience reimagines biopharmaceutical manufacturing, building a high-tech network of labs across North America to safely and rapidly produce complex medicines like cell and gene therapies, aiming to broaden access and protect crucial supply chains against disruption.
Repligen fuels the production of biologic drugs like monoclonal antibodies by developing and selling high-tech materials used in their purification process, helping countless patients by empowering biotech companies to bring vital medications to market efficiently.
Danaher is a global life sciences and diagnostics powerhouse, accelerating innovations in biopharmaceuticals, medical testing, and life science tools. They equip researchers and companies with expertise, tools, and services to develop and deliver life-changing therapies faster and more safely, ultimately aiming to improve health and sustainability for billions worldwide.
Tecan empowers scientists and researchers in life sciences, forensics, and medical technology by crafting high-precision laboratory automation solutions and instruments. Their robots, readers, and software help automate tedious tasks, accelerate research, and improve accuracy, ultimately contributing to medical advancements and a healthier future.
FormFactor is a tech leader in the semiconductor industry, crafting tiny, robust electrical probes that test chips millions of times over. They provide essential test and measurement technologies for every stage of a chip’s life cycle, enabling engineers to optimize performance and boost yields, from characterization to production.
FUJIFILM Diosynth Biotechnologies is a CDMO partner for life, combining technical expertise in cell culture, fermentation, and gene therapies with world-class cGMP facilities to advance tomorrow’s medicines. They support clients with developing and manufacturing a range of products, from recombinant proteins to viral vaccines and gene therapies, ultimately aiding the creation of cures and improvements in healthcare.
Regeneron develops cutting-edge antibody medicines to tackle serious diseases across diverse fields like ophthalmology, oncology, and cardiology. They harness their deep understanding of human genetics and protein science to create innovative therapies, aiming to bring hope and transformative treatments to patients in need.
Corning has combined its unparalleled expertise in glass science, ceramics science, and optical physics with deep manufacturing and engineering capabilities to develop life-changing innovations and products.
Endress+Hauser is a global giant in measuring instruments and automation solutions for process and laboratory applications. Think sensors, meters, and software helping factories, power plants, and labs across countless industries monitor, control, and optimize their operations – from flow and pressure to temperature and liquid analysis. Essentially, they’re the invisible backbone keeping industrial processes running smoothly and safely.
Terumo Blood and Cell Technologies (Terumo BCT) specializes in blood components separation and processing, therapeutic apheresis (removing specific components from blood for treatment), and cellular technologies, contributing to healthcare by sustaining blood transfusions, blood and cell therapies, and related care across over 130 countries and regions globally. They’re essentially the unsung heroes behind the safe and effective use of blood and its valuable components for medical treatments.